3,4-Epoxycyclohexane Carboxylic Acid, Methyl Ester (CAS 41088-52-2) Technical Guide
Table of Contents
- Product Overview & Specifications
- Key Applications & Industry Uses
- Performance Comparison Table
- Industrial Application Case Studies
- Customer Success Stories
- Request Customized Solutions
Product Overview & Specifications
| Parameter | Specification |
|---|---|
| CAS Number | 41088-52-2 |
| Molecular Formula | C9H12O3 |
| Molecular Weight | 168.19 g/mol |
| Appearance | Clear colorless to pale yellow liquid |
| Purity | ≥98% (GC) |
| Storage Conditions | 2-8°C in inert atmosphere |
Key Applications & Industry Uses
1. Epoxy Resin Monomer
Used as reactive diluent in high-performance epoxy systems for aerospace composites, showing 20% better thermal stability than DGEBA analogs.
2. Pharmaceutical Intermediate
Critical precursor for synthesizing neuraminidase inhibitors, with batch consistency meeting USP Class 2 impurity limits (<0.15%).
3. Advanced Coatings
Enhances UV resistance in automotive clearcoats, achieving 500h QUV exposure without yellowing.
Performance Comparison Table
| Property | This Product | Epoxidized Soybean Oil | Vinylcyclohexene Dioxide |
|---|---|---|---|
| Epoxide Value (eq/kg) | 5.8-6.2 | 4.0-4.5 | 6.5-7.0 |
| Viscosity @25°C (cP) | 150-200 | 800-1200 | 50-80 |
| HDT (°C) | 185 | 120 | 210 |
Industrial Application Case Studies
Case 1: Aerospace Composite Optimization
Challenge: Reduce viscosity of carbon fiber prepreg resin without compromising Tg.
Solution: 15% substitution of DGEBA with our product.
Result: Viscosity reduced from 12,000cP to 4,500cP, Tg maintained at 180°C.
Case 2: Antiviral Drug Synthesis
Challenge: Improve stereochemical control in oseltamivir intermediate.
Solution: Used as chiral building block in step 3 synthesis.
Result: Overall yield increased from 42% to 68%, enantiomeric excess >99.5%.
Customer Success Stories
Customer A: European Specialty Chemicals Manufacturer
Application: High-purity electronic encapsulant for 5G modules
Volume: 800kg/month
Benefit: Achieved CTE of 45ppm/°C vs. industry standard 60ppm
Customer B: Japanese Pharma Company
Application: COVID-19 therapeutic candidate intermediate
Volume: 120kg batch production
Benefit: Reduced synthesis steps from 7 to 4, cutting production costs by 35%
Request Customized Solutions
Our technical team offers:
- Custom purity grades (98%-99.9%)
- Bulk quantities up to 20MT/month
- Regulatory support for FDA/REACH compliance
Contact our specialists:
Email: info@vivalr.com
Tel: (86) 15866781826



评论
目前还没有评论。